EYEG
AB Corporate Bond ETF
stockNASDAQETF
At CloseOct 20, 2026 9:47:43 AM EDT
33.56USD0.000%(+33.56)90
Loading…
Loading…
27.00M
Healthcare
Biotechnology
HQ
Waltham, MA, USA
Previous Close
$33.88
Beta
0.17
52-Week High
$36.63 2025-10-27
52-Week Low
$33.24 2026-10-02
SMA 50
$33.99
SMA 200
$35.00
Avg. Vol 10D
5,272
Avg. Vol 30D
2,050
Avg. Vol 90D
974
Relative Vol
0.04
800,000
965,320
120.67%
0.05%
1.24
88%/12%
0.00%
30.8600%
71
302
1,485
Sep 2, 2025 · $0.142
Aug 30, 2019 · 1-for-15 (reverse)
Oct 1, 2026
AB Corporate Bond ETF declares $0.1367 dividend · 
Seeking Alpha
EYEG Profile
Eyegate Pharmaceuticals Inc focuses on developing and commercializing products for treating diseases and disorders of the eye.
EYEG Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 33.66 | 2026-10-16 | +0.28% | -0.562 |
| 1M | 33.82 | 2026-09-23 | -0.19% | -0.083 |
| 3M | 34.55 | 2026-07-23 | -2.30% | 0.167 |
| 6M | 35.48 | 2026-04-23 | -4.87% | 0.181 |
| 1Y | 36.42 | 2025-10-23 | -7.33% | 0.165 |
| 2Y | 35.96 | 2024-10-23 | -6.13% | — |
| 5Y | 1.86 | 2021-10-22 | +1714.79% | 3.442 |
EYEG Stock Summary
AB Corporate Bond ETF (NASDAQ:EYEG) stock price today is $33.76, and today's volume is 88. EYEG is down 0.354% today. The 30 day average volume is 2,050. EYEG market cap is $27.00M with 800,000 shares outstanding.